China
biliary tract cancer; lenvatinib; nivolumab; pembrolizumab; combined immunotherapy
hepatocellular cancer; 3D bio-printing; patient-derived cancer models; drug screening; personalized treatment
gallbladder stones, bile duct stones, prevalence, risk factors, epidemiology